Pharmadule Engineering India Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 5.00 Cr
- Company Age 7 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 25.76%
- Profit Growth -48.43%
- Ebitda -22.51%
- Net Worth 35.00%
- Total Assets 41.07%
About Pharmadule Engineering India
Pharmadule Engineering India Private Limited (PEIPL) is a Private Limited Foreign Company Incorporated In India incorporated in India on 15 May 2017 (Seven years and eight months 17 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Engineering Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 5.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Gu Zhenghui, Kazuaki Sanada, and Gausmohmmad Khan serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U29309MH2017FTC294872
-
Company No.
294872
-
Company Classification
Private Limited Foreign Company Incorporated In India
-
Incorporation Date
15 May 2017
-
Date of AGM
29 Jul 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Pharmadule Engineering India?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gu Zhenghui
|
Director | 15-May-2017 | Current |
Kazuaki Sanada
|
Director | 15-May-2017 | Current |
Gausmohmmad Khan
|
Director | 23-Oct-2017 | Current |
Financial Performance of Pharmadule Engineering India.
Pharmadule Engineering India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 25.76% increase. The company also saw a substantial fall in profitability, with a 48.43% decrease in profit. The company's net worth Soared by an impressive increase of 35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmadule Engineering India?
In 2022, Pharmadule Engineering India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pharmadule Engineering India?
Pharmadule Engineering India has a workforce of 71 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmadule Engineering India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmadule Engineering India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
